Skip to content

Gastric pH in Critically Ill Patients

Effect of Intravenous Esomeprazole Versus Ranitidine on Gastric pH in Critically Ill Patients - a Prospective, Randomized, Double-Blind Study.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00590928
Enrollment
75
Registered
2008-01-11
Start date
2004-07-31
Completion date
2006-06-30
Last updated
2008-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically Ill Patients, Indication for Stress Ulcer Prophylaxis

Brief summary

H2-receptor antagonists are the gold standard for stress ulcer prophylaxis in critically ill patients. Various studies demonstrated superiority of proton pump inhibitors over H2-receptor antagonists in increasing gastric pH and in healing gastric acid-dependent diseases. It is unknown, whether proton pump inhibitors are more effective in increasing gastric pH than H2-receptor antagonists in critically ill patients requiring stress ulcer prophylaxis.

Detailed description

Gastric pH is measured continuously for 72 hours with a pipolar microelectrode placed between 7 and 15cm below the lower esophageal sphincter.

Interventions

DRUGesomeprazole

40mg once daily

DRUGranitidine

50mg every h hours

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* critically ill patients * indication for stress ulcer prophylaxis * gastric pH \< 4

Exclusion criteria

* gastrointestinal bleeding * gastric pH \> 4

Design outcomes

Primary

MeasureTime frame
the percentage of time with gastric pH > 472 hours

Secondary

MeasureTime frame
median gastric pH72 hours
incidence of gastrointestinal bleeding72 hours
incidence of ventilator associated pneumoniaICU stay
the percentage of time with an gastric pH > 572 hours

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026